Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leu... by Yang Dai, Jingcao Huang, Bing Xiang, Huanling Zhu, Chuan He

Get full text

Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors by Yan Li, Pu Kuang, Huanling Zhu, Ling Pan, Tian Dong, Ting Lin, Yu Chen, Yunfan Yang

Get full text

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes by Yao Qin, Hang Zhang, Lin Feng, Haichen Wei, Yuling Wu, Chaoran Jiang, Zhihong Xu, Huanling Zhu, Ting Liu

Get full text

PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC... by Weiming LI, Na Xu, Zhongyuan Xu, Yanli Zhang, Junmin LI, Huanling Zhu, LI Zheng, Xiaojing Yan, Xin Du, Yu Hu

Get full text

Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year res... by Jorge E. Cortes, Qian Jiang, Jianxiang Wang, Jianyu Weng, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong-Wook Kim, Jerald Radich, Michael Savona, Patricia Martin-Regueira, Oumar Sy, Giuseppe Saglio

Get full text

Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China by Yunfan Yang, Yanli Zhang, Qian Jiang, Li Meng, Weiming Li, Bingcheng Liu, Xiaoli Liu, Li Zhou, Rong Liang, Xiaojian Zhu, NaXu, Pu Kuang, Ting Lin, Huanling Zhu, Peng Lyu

Get full text

Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services by Mei Bao, Sen Yang, Robert Peter Gale, Yanli Zhang, Xiaoli Liu, Huanling Zhu, Rong Liang, Bingcheng Liu, Li Zhou, Zongru Li, Xuelin Dou, Dayu Shi, Tao Wang, Li Meng, Weiming Li, Qian Jiang

Get full text

P1021: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE INTOLERANT TO RUXOLITINIB: AN OPEN-LABEL, SINGLE-ARM PHASE 2B STUDY by Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin LI, Liangming MA, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin LI, Qingchi Liu, Wei Wang, Xu Na, Haiping Yang, Qingwei Zhao, Jie Jin

Get full text

Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia by Yunfan Yang, Yuntao Liu, Hui Sun, Li Meng, Hai Lin, Chunyan Chen, Jianda Hu, Xuliang Shen, Minghui Duan, Yanli Zhang, Dilinazi Abulaiti, Jinghua Wang, Hongqian Zhu, Luoming Hua, Qing Leng, Chun Zhang, Lili Sun, Weiming Li, Huanling Zhu, Bingcheng Liu, Jianxiang Wang

Get full text

PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY by Ziyu LI, Qian Jiang, Xiaoshuai Zhang, Yanli Zhang, Na Xu, Huanling Zhu, Hai Lin, Weiming LI, Xin Du, Rong Liang, Fei LI, Chunyan Chen, Bingcheng Liu, Xiaodong Wang, Lijie Yang, Zhenfang Liu, Liping Pang, Zhuogang Liu, Xiuli Sun, Yanliang Bai, LI Meng, Suning Chen

Get full text

Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia by Yilin Chen, Na Xu, Yunfan Yang, Zhenfang Liu, Mengxing Xue, Li Meng, Qun He, Chunyan Chen, Qingshu Zeng, Huanling Zhu, Xin Du, Jing Zou, Wenjun He, Jingming Guo, Suning Chen, Guolin Yuan, Hui Wu, Mei Hong, Fanjun Cheng, Bingcheng Liu, Yanli Zhang, Weiming Li

Get full text

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, m... by Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu, Bingcheng Liu, Yanli Zhang, Li Meng, Huanling Zhu, Xin Du, Suning Chen, Yang Liang, Yu Hu, Xiaoli Liu, Yongping Song, Lichuang Men, Zi Chen, Qian Niu, Hengbang Wang, Ming Lu, Dajun Yang, Yifan Zhai, Xiaojun Huang

Get full text

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter p... by Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu, Bingcheng Liu, Yanli Zhang, Li Meng, Huanling Zhu, Xin Du, Suning Chen, Yang Liang, Yu Hu, Xiaoli Liu, Yongping Song, Lichuang Men, Zi Chen, Qian Niu, Hengbang Wang, Ming Lu, Dajun Yang, Yifan Zhai, Xiaojun Huang

Get full text

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, m... by Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu, Bingcheng Liu, Yanli Zhang, Li Meng, Huanling Zhu, Xin Du, Suning Chen, Yang Liang, Yu Hu, Xiaoli Liu, Yongping Song, Lichuang Men, Zi Chen, Qian Niu, Hengbang Wang, Ming Lu, Dajun Yang, Yifan Zhai, Xiaojun Huang

Get full text

S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS by Yi Zhang, Hu Zhou, Junling Zhuang, Aili He, Yarong LI, Linhua Yang, Xin Du, Sujun Gao, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Sun Kai, Lingling Yue, Cuiping Zheng, Zeping Zhou, Chenghao Jin, Hongmei Jing, Lin Liu, Qingchi Liu, Jishi Wang, Wen Wu, Yajing Xu, Dengshu Wu, Na Xu, Feng Zhang, Jin Zhang, Huanling Zhu, Zhijian Xiao, Jie Jin

Get full text

Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study by Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Qingchi Liu, Xin Du, Sujun Gao, Yarong Li, Yan Li, Yuqing Chen, Wen Wu, Huanling Zhu, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Hongmei Jing, Jishi Wang, Na Xu, Lingling Yue, Cuiping Zheng, Zeping Zhou, Chenghao Jin, Xin Li, Lin Liu, Yajing Xu, Dengshu Wu, Feng Zhang, Jin Zhang, Liqing Wu, Hewen Yin, Binhua Lv, Zhijian Xiao, Jie Jin

Get full text